K.U. LEUVEN RESEARCH AND DEVELOPMENT Patent applications |
Patent application number | Title | Published |
20130096079 | Anti-Viral Pyrimidine Nucleoside Derivatives - A compound for use in the treatment or prophylaxis of viral infections such, for example as chicken pox or shingles caused by the Varicella Zoster virus, said compound having the general formula (II): wherein X is O, S, NH or CH | 04-18-2013 |
20110033911 | Episomal fusion gene - The present invention relates to an episomal structure expressing a functional oncogene, whereby said oncogene is a fusion gene of two chromosomal gene fragments. More specifically, the invention relates to a NUP214-ABL1 fusion product, important in the development of T-cell acute lymphoblastic leukemia, to methods to detect the fusion and to methods to prevent the oncogenic activity of said fusion product. | 02-10-2011 |
20100160455 | VITAMIN D3 ANALOGUES FOR THE PREVENTION AND TREATMENT OF BONE DISORDERS - Novel vitamin D analogues are useful for making pharmaceutical compositions for the prevention or treatment of bone disorders such as osteoporosis | 06-24-2010 |
20100040816 | SILK FIBRE COMPOSITES - The present invention provides silk fibre reinforced composite materials comprising a thermoplastic polymer matrix, which are relatively light, whilst having a high impact resistance. The silk fibre reinforced composite materials of the present invention allow for an optimal dissipation of the impact energy such that they have a penetration resistance higher than 20 J per mm of plate thickness, more preferably more than 30 J per mm, most preferably more than 40 J per mm. Due to the high impact resistance of the fibrous composite material according to the present invention, panels or shells comprising such composites are particularly useful for the manufacture of objects, which in the course of their life cycle are subject to shocks or at risk of penetration. | 02-18-2010 |
20080261905 | Modified Nucleosides for Rna Interference - The present invention relates to the use of modified nucleotides and single or double stranded oligonucleotides having at least one of said modified nucleotides for performing RNA interference. The modified nucleotides are selected from 6-membered ring containing nucleotides such as hexitol, altritol, O-substituted or O-alkylated altritol, cyclohexenyl, ribo-cyclohexenyl and O-substituted or O-alkylated ribo-cyclohexenyl nucleotides. The present invention also relates to novel modified nucleosides or nucleotides and to the use of the novel modified nucleosides and nucleotides in single or double stranded oligonucleotides for RNA interference, antisense therapy or other applications. | 10-23-2008 |